Johns Hopkins University Begin Follow-On Study

08-Jul-2016 Researchers at the Johns Hopkins University School of Medicine have begun work on a 1000 patient study to further demonstrate the clinical utility of Sienna’s telomerase detection technology as an aid in the diagnosis of bladder cancer alongside standard urine cytology testing. This new study is a follow-on to the recently completed and successful proof-of-concept study which showed positive results in this application.

“Johns Hopkins is a prestigious and highly respected clinical research institution. The fact that they have seen enough proof of clinical utility to now pursue a study of this size, speaks volumes for the potential this new test has in the clinical pathology laboratory environment” said Sienna COO, Matthew Hoskin.


No Very

Captcha Image

Sign up for updates